Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-10-003331
Filing Date
2010-02-03
Accepted
2010-02-03 16:10:25
Documents
1
Period of Report
2010-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7375
  Complete submission text file 0001127602-10-003331.txt   8992
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
ROTHBLATT MARTINE A (Reporting) CIK: 0001106578 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 10570802